Finance ❯ Stock Market ❯ Company Performance ❯ Market Reactions

Investor Sentiment

Hims & Hers Halts $49 Compounded Wegovy Pill as FDA Tightens GLP-1 Rules

Federal officials moved to curb mass compounding, with a DOJ referral citing safety and misleading marketing concerns.

SEC Probing AppLovin’s Data Practices After Whistleblower, Reports Say

Tesla Launches Lower-Priced 'Standard' Model 3 and Model Y

Acadia Halts Carbetocin for Prader-Willi After Phase 3 Miss

FDA Lifts Hold on Elevidys Shipments to Ambulatory Duchenne Patients

UNFI Cyberattack Leaves Whole Foods Facing Empty Shelves as System Restorations Drag On

Reddit Sues Anthropic Over Unauthorized Data Scraping

Victoria’s Secret Website Restored After Memorial Day Security Outage

Tesla’s April Sales in Europe Fall 49% as BYD Overtakes Market Lead